Centre Defends Free-Market Drug Pricing; SC Pushes For Uniform 16% Margin Ceiling
The Centre has proposed a 30% ceiling on trade margins for 138 anti-cancer medicines, arguing before the Supreme Court that sweeping price controls could jeopardise drug supplies and disrupt the market.
